Supports the designation of "ALS Awareness Month".

This resolution supports the designation of ALS Awareness Month. Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, also known as Lou Gehrig's disease, that affects nerve cells in the brain and spinal cord.

Bill 118 HRES 374, also known as the "Supports the designation of ALS Awareness Month" bill, is a piece of legislation introduced in the US Congress. The purpose of this bill is to officially recognize and support the designation of May as ALS Awareness Month. ALS, also known as Amyotrophic Lateral Sclerosis or Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

The bill highlights the importance of raising awareness about ALS and the impact it has on individuals and their families. By designating May as ALS Awareness Month, the bill aims to increase public understanding of the disease, promote research efforts, and support those affected by ALS.

The legislation emphasizes the need for continued research and funding to find a cure for ALS, as well as to improve treatment options and support services for individuals living with the disease. It also recognizes the contributions of healthcare professionals, researchers, and advocates who work tirelessly to support those affected by ALS. Overall, Bill 118 HRES 374 seeks to bring attention to ALS and the challenges faced by individuals living with the disease. By officially designating May as ALS Awareness Month, the bill aims to raise awareness, promote research, and support those affected by ALS in their fight against this devastating illness.